Aspects of the drug patent system make it challenging for companies to earn the sales
revenues needed to recoup costs of research and development. First, the time between …

cepr Page 1 cepr CENTER FOR ECONOMIC AND POLICY RESEARCH Briefing Paper Promoting
Good Ideas on Drugs: Are Patents the Best Way? The Relative Efficiency of Patent and Public …

The global system of drug development and marketing is broken. Research spending is
misdirected into products which add little therapeutic value to the medicine chest; and high …

Patent grants are insensitive to economic considerations such as investment risks and
expectations. In the pharmaceutical industry, the granting of identical rewards for different …

US pharmaceutical patent policy is poised for a major review by the US Supreme Court.
Later this month, the Court will hear a case, Federal Trade Commission (FTC) v. Actavis …

In today's fast-paced world where Americans crave a quick fix to their medical woes, it takes
more than advice on a healthy lifestyle to satisfy consumers. But along with cutting-edge …

Pharmaceutical research and development (R&D) involves both the creation of new
products and the production of information about their effects through preclinical research …

Recently there has been a considerable amount of pressure to accelerate consumer access
to generic drugs, which are significantly less expensive than their brand-name counterparts …

This Article examines a relatively new business strategy in the pharmaceutical market-"
product hopping" or" product replacement"-in which brand pharmaceutical companies shift …

Pharmaceutical companies face a very hostile competitive environment from generic drugs
once the patents on their brand name drugs expire. Depending on the country, such patents …